Developer docs
API playgroundTry for free, no card

Search company profiles

WhizAI

Full company profile

uuid0004411

Namestring
WhizAI
Legal namestring
WhizAI
Websiteurl
whiz.ai
Company typeenum
Private
Founded yearint
2017
Descriptiontext

WhizAI is an AI-powered conversational analytics platform purpose-built for the life sciences and healthcare industry, operating as a wholly-owned business unit of IQVIA within its Analytics, Insights & Reporting (AIR) portfolio. The platform is built on two proprietary technical components: an 'intent-ready' natural language processing engine that interprets user intent in domain-specific life sciences contexts, and a domain-tuned large language model (LLM) specifically optimized for healthcare and pharmaceutical data. Together these components enable business users to query complex healthcare and pharmaceutical datasets in natural language and receive precise, context-aware analytical responses, effectively transforming raw data into strategic intelligence for non-technical users.

The company serves two primary verticals: life sciences organizations (pharmaceutical manufacturers and biotech companies) requiring advanced data-driven insights for commercial decision-making, and broader healthcare organizations (providers, hospital systems, payers) seeking AI-augmented analytics for operational optimization. WhizAI's go-to-market is exclusively through IQVIA's global direct enterprise field sales force, which targets pharmaceutical manufacturers, MedTech, and healthcare organizations with deep domain expertise. Revenue is generated through enterprise licensing and analytics services bundled within IQVIA's broader commercial analytics ecosystem; pricing is not publicly disclosed and is tailored per engagement.

Operationally, WhizAI maintains a workforce of 51-100 employees and is headquartered in Somerset, United States. The company has raised approximately $20.2M in disclosed funding across four rounds between 2018 and 2022, with investors including Cencora, Shanda Group, Vertical Venture Partners, Healthy Ventures, Bling Capital, Firebolt Ventures, and Trigyn Technologies. It was co-founded by Rohit Vashisht (CEO) and Amitabh Patil (CPTO). WhizAI was recognized as one of the top 30 vendors in Gartner's 2025 Market Guide for Agentic Analytics.

Short descriptiontext

WhizAI is an IQVIA-owned, GenAI-powered conversational analytics platform that lets life sciences and healthcare organizations query complex pharmaceutical and clinical data in natural language using a proprietary intent-ready NLP and domain-tuned LLM for faster, more precise decision-making.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersSomerset, United States
HQ citystring
Somerset
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
conversational analytics, life sciences analytics, healthcare AI platform, GenAI enterprise software, augmented analytics
Industry4 codes
PRIMARYHDAAADAF
Conversational NLP & Dialogue Management (chatbots, agents)
SECONDARYHLAGAJAN
Knowledge Management & Scientific Collaboration / Literature Intelligence
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHDAAADAC
Question Answering & Retrieval-Augmented Generation (RAG)
SECONDARYBPAEAHAG
Generative AI & LLM Solutions Services (RAG, Agents, Copilots)
NAICS code2 codes
  • Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services5182
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code1 code
  • Services-Computer Integrated Systems Design7373
Product category
Healthcare Analytics Software
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Enterprise Analytics Solutions
TypeSubscription Recurring
Description

WhizAI is offered as part of IQVIA's broader Analytics, Insights & Reporting (AIR) solutions portfolio, providing GenAI-powered conversational analytics capabilities to life sciences and healthcare organizations. Revenue is generated through enterprise licensing and analytics services within the IQVIA commercial analytics ecosystem.

iqvia.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

WhizAI is a GenAI-powered conversational analytics platform that uses proprietary intent-ready NLP and a domain-tuned LLM to transform complex life sciences and healthcare data into strategic intelligence. Users interact with the platform through natural language queries to generate fast, precise insights for business decision-making. It is sold as part of IQVIA's Analytics, Insights & Reporting (AIR) suite to pharmaceutical manufacturers, biotech firms, MedTech companies, and healthcare organizations globally.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

WhizAI is a GenAI-powered conversational analytics platform offered as part of IQVIA's Analytics, Insights & Reporting (AIR) suite. It provides a proprietary intent-ready NLP and domain-tuned LLM that enables life sciences professionals to query data and receive insights through natural language interactions. WhizAI is designed specifically for the life sciences industry, transforming complex healthcare and pharmaceutical data into strategic intelligence for informed decision-making.

Product and service1 record
1WhizAI Conversational Analytics Platform
CategoryHealthcare Analytics Software
Description

GenAI-powered conversational analytics platform that uses proprietary intent-ready NLP and a domain-tuned LLM to transform complex life sciences and healthcare data into strategic intelligence through natural language queries. It is designed for pharmaceutical manufacturers, biotech, MedTech, and healthcare organizations seeking fast, intuitive access to data for business decision-making.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeOthers
Description

WhizAI is an IQVIA business, operating as a wholly-owned subsidiary and product within the IQVIA Analytics, Insights & Reporting (AIR) portfolio. This is a parent-subsidiary relationship where WhizAI's technology is integrated into IQVIA's broader healthcare-grade AI and commercial analytics ecosystem.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors7 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

WhizAI

Healthcare Analytics Softwarewhiz.ai

WhizAI is an IQVIA-owned, GenAI-powered conversational analytics platform that lets life sciences and healthcare organizations query complex pharmaceutical and clinical data in natural language using a proprietary intent-ready NLP and domain-tuned LLM for faster, more precise decision-making.

What WhizAI does

WhizAI is an AI-powered conversational analytics platform purpose-built for the life sciences and healthcare industry, operating as a wholly-owned business unit of IQVIA within its Analytics, Insights & Reporting (AIR) portfolio. The platform is built on two proprietary technical components: an 'intent-ready' natural language processing engine that interprets user intent in domain-specific life sciences contexts, and a domain-tuned large language model (LLM) specifically optimized for healthcare and pharmaceutical data. Together these components enable business users to query complex healthcare and pharmaceutical datasets in natural language and receive precise, context-aware analytical responses, effectively transforming raw data into strategic intelligence for non-technical users.

The company serves two primary verticals: life sciences organizations (pharmaceutical manufacturers and biotech companies) requiring advanced data-driven insights for commercial decision-making, and broader healthcare organizations (providers, hospital systems, payers) seeking AI-augmented analytics for operational optimization. WhizAI's go-to-market is exclusively through IQVIA's global direct enterprise field sales force, which targets pharmaceutical manufacturers, MedTech, and healthcare organizations with deep domain expertise. Revenue is generated through enterprise licensing and analytics services bundled within IQVIA's broader commercial analytics ecosystem; pricing is not publicly disclosed and is tailored per engagement.

Operationally, WhizAI maintains a workforce of 51-100 employees and is headquartered in Somerset, United States. The company has raised approximately $20.2M in disclosed funding across four rounds between 2018 and 2022, with investors including Cencora, Shanda Group, Vertical Venture Partners, Healthy Ventures, Bling Capital, Firebolt Ventures, and Trigyn Technologies. It was co-founded by Rohit Vashisht (CEO) and Amitabh Patil (CPTO). WhizAI was recognized as one of the top 30 vendors in Gartner's 2025 Market Guide for Agentic Analytics.

WhizAI firmographics

Firmographics
Name
WhizAI
Legal name
WhizAI
Website
https://whiz.ai
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
51–100 employees
Short description
WhizAI is an IQVIA-owned, GenAI-powered conversational analytics platform that lets life sciences and healthcare organizations query complex pharmaceutical and clinical data in natural language using a proprietary intent-ready NLP and domain-tuned LLM for faster, more precise decision-making.
Ownership category
akta.pro rank

WhizAI industry classification

Industry
Product category
Healthcare Analytics Software
NAICS
Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (5182), Research and Development in the Physical, Engineering, and Life Sciences (54171)
SIC
Services-Computer Integrated Systems Design (7373)
akta.pro industry
PRIMARYHDAAADAF
Conversational NLP & Dialogue Management (chatbots, agents)
SECONDARYHLAGAJAN
Knowledge Management & Scientific Collaboration / Literature Intelligence
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHDAAADAC
Question Answering & Retrieval-Augmented Generation (RAG)
SECONDARYBPAEAHAG
Generative AI & LLM Solutions Services (RAG, Agents, Copilots)

Keywords

  • Conversational analytics
  • Life sciences analytics
  • Healthcare AI platform
  • GenAI enterprise software
  • Augmented analytics

Where WhizAI is headquartered

Location

Headquarters

HQ city
Somerset
HQ country
United States
HQ region
North America

Offices1 record

Markets served

WhizAI business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations

Revenue model

  1. Enterprise Analytics Solutions: WhizAI is offered as part of IQVIA's broader Analytics, Insights & Reporting (AIR) solutions portfolio, providing GenAI-powered conversational analytics capabilities to life sciences and healthcare organizations. Revenue is generated through enterprise licensing and analytics services within the IQVIA commercial analytics ecosystem.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

WhizAI product offering

Product offering

Core offering

WhizAI is a GenAI-powered conversational analytics platform that uses proprietary intent-ready NLP and a domain-tuned LLM to transform complex life sciences and healthcare data into strategic intelligence. Users interact with the platform through natural language queries to generate fast, precise insights for business decision-making. It is sold as part of IQVIA's Analytics, Insights & Reporting (AIR) suite to pharmaceutical manufacturers, biotech firms, MedTech companies, and healthcare organizations globally.

Product overview

WhizAI is a GenAI-powered conversational analytics platform offered as part of IQVIA's Analytics, Insights & Reporting (AIR) suite. It provides a proprietary intent-ready NLP and domain-tuned LLM that enables life sciences professionals to query data and receive insights through natural language interactions. WhizAI is designed specifically for the life sciences industry, transforming complex healthcare and pharmaceutical data into strategic intelligence for informed decision-making.

Differentiator

Problem solved

Functional benefit

Products and services

  • WhizAI Conversational Analytics Platform GenAI-powered conversational analytics platform that uses proprietary intent-ready NLP and a domain-tuned LLM to transform complex life sciences and healthcare data into strategic intelligence through natural language queries. It is designed for pharmaceutical manufacturers, biotech, MedTech, and healthcare organizations seeking fast, intuitive access to data for business decision-making.

Companies that use WhizAI

Customer profile

Segments2 records

Ideal customer profiles2 records

WhizAI technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature3 records

WhizAI partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • IQVIAcoreOthersWhizAI is an IQVIA business, operating as a wholly-owned subsidiary and product within the IQVIA Analytics, Insights & Reporting (AIR) portfolio. This is a parent-subsidiary relationship where WhizAI's technology is integrated into IQVIA's broader healthcare-grade AI and commercial analytics ecosystem.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

WhizAI competitors and assessment

Company assessment

Market position

Strengths4 records

Competitive moat5 records

Key risks5 records

Key highlights5 records

Customer concentration

WhizAI social profiles

Digital presence

WhizAI financial estimates

Financial estimate

Revenue estimate

Valuation estimate

WhizAI leadership team

Management profile

Number of profiles

Profiles2 records

WhizAI funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

WhizAI M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about WhizAI

What does WhizAI do?

WhizAI is a GenAI-powered conversational analytics platform that uses proprietary intent-ready NLP and a domain-tuned LLM to transform complex life sciences and healthcare data into strategic intelligence. Users interact with the platform through natural language queries to generate fast, precise insights for business decision-making. It is sold as part of IQVIA's Analytics, Insights & Reporting (AIR) suite to pharmaceutical manufacturers, biotech firms, MedTech companies, and healthcare organizations globally.

Is WhizAI a public or private company?

WhizAI is a private company. It is classified as corporate owned and is currently operating.

When was WhizAI founded?

WhizAI was founded in 2017. It employs 51 to 100 people.

Where is WhizAI based?

WhizAI is headquartered in Somerset, United States, in the North America region.

How does WhizAI make money?

One revenue line is on record: enterprise Analytics Solutions.

Does WhizAI have an API?

No public API is recorded for WhizAI.

What industry is WhizAI in?

WhizAI's product category is Healthcare Analytics Software. Its primary akta.pro industry code is HDAAADAF, Conversational NLP & Dialogue Management (chatbots, agents), with a secondary code of HLAGAJAN, Knowledge Management & Scientific Collaboration / Literature Intelligence. Its NAICS code is 5182 and its SIC code is 7373.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
TrinitylifesciencesTrinity Life Sciences and WhizAI Announce AI Analytics PartnershipTrinity Life Sciences and WhizAI announced a partnership to integrate WhizAI’s conversational AI analytics platform with Trinity’s data management solutions for the life sciences sector. This combined offering aims to accelerate time-to-insights for commercial teams by enabling rapid generation of customized data visualizations and dashboards through augmented analytics.Business Wire BlogWhizAI Redefines Life Sciences Analytics: Domain-Tuned LLM and Intent-Ready NLP Sets a New Industry StandardWhizAI unveiled an updated version of its generative AI-powered analytics platform for the life sciences sector, integrating a domain-tuned Large Language Model with an intent-ready NLP engine. The update aims to improve accuracy and data privacy while reducing operational costs by eliminating the need for customers to provision expensive GPUs for model training. This release positions WhizAI as a provider of pre-trained insights tailored specifically for clinical discovery and commercial success.openPR.comAI in Life Science Analytics Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031The global AI in life science analytics market is projected to grow at a 9.7% CAGR from 2024 to 2031. AI applications include drug discovery, clinical trials, and disease diagnosis, with Google Cloud and TrinityLife/WhizAI partnership cited as growth drivers.FiercePharmaReal Chemistry, WhizAI hook up to use generative AI for patient journey mappingReal Chemistry and WhizAI have partnered to launch a generative AI platform designed for patient journey mapping in the pharmaceutical industry. The collaboration combines Real Chemistry's analytics engine with WhizAI's visualization tools to provide real-time insights into patient diagnostic and treatment pathways. This initiative aims to help drugmakers market more authentically by identifying opportunities to improve care processes.FinSMEsWhizAI Closes Funding RoundWhizAI, a life sciences analytics provider based in Somerset, NJ, has closed a funding round led by Shanda Group and AmerisourceBergen’s AB Health Ventures, bringing its total funding since 2017 to $21 million. The company plans to utilize the capital to expand its presence among global pharmaceutical clients, form strategic partnerships, and enhance its engineering and sales capabilities.Pulse 2.0WhizAI Secures $8 Million In Series A FundingWhizAI raised $8 million in Series A financing led by Vertical Venture Partners, with existing investors participating. The round brings total funding to over $15 million. The company will use the investment to expand its footprint in the US and Europe.dlvr.itWhizAI Secures $8 Million In Series A FundingWhizAI has secured $8 million in Series A funding led by Vertical Venture Partners, bringing its total capital raised to over $15 million. The company utilizes augmented analytics to help life sciences firms reduce costs and streamline operations through intelligent automation. WhizAI intends to use the new investment to expand its market presence in the US and Europe.Business Wire BlogWhizAI Raises $8M in Series A Financing to Bring the Future of Analytics to the Life Sciences Industry .WhizAI raised $8 million in Series A financing led by Vertical Venture Partners, bringing total funding to over $15 million. The company will use the capital to expand its US and European footprint and invest in sales and marketing.Business Wire BlogWhizAI Partners With Snowflake To Combine Augmented Analytics With Scalability And Performance For Life Science CustomersWhizAI announced a partnership with Snowflake to combine its augmented analytics platform with Snowflake's Data Cloud for life sciences customers. The collaboration aims to provide faster access to data-driven insights with scalability and performance. WhizAI claims 100% adoption, 50% TCO reduction, and 5X productivity for its clients.BufferTech Trends: Somerset-based WhizAI gets $4M to make business intelligence easy for pharma, life sciencesWhizAI, a Somerset-based company specializing in artificial intelligence for the pharmaceutical and life sciences sectors, has secured an additional $4 million in funding to scale its software offerings. The investment, led by Healthy Ventures, brings WhizAI's total funding to over $6.5 million and is aimed at enhancing their data insights solution, which seeks to simplify the access and analysis of business intelligence for their customers. With increasing demand for innovative solutions in the life sciences due to the COVID-19 pandemic, WhizAI is focused on expanding its market presence and capabilities.